NIH-funded research R01 grant

Understanding how metabolic changes affect Hurthle cell carcinoma of the thyroid

Official title: Identifying metabolic dependencies in Hurthle cell carcinoma of the thyroid-Res 1

Funded at Ut Southwestern Medical Center · NIH-10894805 · Data updated 2026-11-12

This study is looking at how certain changes in the energy-making parts of cells help Hurthle cell carcinoma, a tough type of thyroid cancer, grow, and it hopes to find new treatment options for patients battling this cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startJuly 27, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$503,309
NIH project number5R01CA276527-02
Project IDNIH-10894805 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients diagnosed with Hurthle cell carcinoma or other thyroid and kidney cancers exhibiting mitochondrial mutations.

Less likely to help

Patients with non-cancerous thyroid conditions or those without mitochondrial mutations may not benefit from this research.

What this research studies

This research investigates the metabolic adaptations that support the growth of Hurthle cell carcinoma, a type of aggressive thyroid cancer. It focuses on mutations in the mitochondrial DNA that may influence tumor metabolism and growth. The study employs various innovative methods, including monitoring carbon metabolism in surgical patients and testing new therapeutic options derived from patient models. By exploring these metabolic dependencies, the research aims to uncover potential treatment strategies for patients with this cancer.

Why it matters

Potential benefit: If successful, this research could lead to new targeted therapies for patients with Hurthle cell carcinoma and potentially other related cancers.

How similar studies have gone: Previous research has shown promising results in targeting metabolic pathways in cancer, suggesting that this approach could yield significant insights and advancements.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Mcfadden, David Glenn — Ut Southwestern Medical Center
  • Study coordinator: Mcfadden, David Glenn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.